- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01702818
Stress Hormones, Mood and Women's Sexual Desire (MODEST) (MODEST)
October 15, 2018 updated by: Lori Brotto, University of British Columbia
Women with Hypoactive sexual desire disorder (HSDD) have all measures of testosterone activity comparable to controls but lower levels of dehydroepiandrosterone (DHEA).
Although DHEA is a precursor of testosterone it has other actions including involvement in the stress system.
It is also linked to mood.
This study focuses on measures of childhood stress, current mood and salivary stress hormones, in women with and without HSDD.
We hypothesize that low levels of DHEA reflect dysfunction of the neuroendocrine stress response system involving the brain, pituitary and adrenal glands where DHEA is produced.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
324
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6T 1Z9
- British Columbia Centre for Sexual Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Women with and without a diagnosis of Hypoactive Sexual Desire Disorder (HSDD).
Description
Inclusion Criteria for HSDD Group:
- (1) diagnosis of HSDD
- (2) over 19 years of age
- (3) sexual complaints of low desire of at least 12 months duration.
Inclusion criteria for Control group:
- (1) sexually healthy, i.e., must not meet criteria for any sexual dysfunction, as determined by a telephone screening, followed by an in-person structured assessment, the Decreased Sexual Desire Screener (DSDS)
- (2) over 19 years of age.
Exclusion Criteria for both Control and HSDD groups:
- (1) lack of fluency in English
- (2) currently meeting DSM-IV-TR diagnostic criteria for major depressive disorder as measured by an in-person, semi-structured interview based on the Major Depressive Disorder Module of the Structured Clinical Interview for DSM-IV-TR (SCID-I
- (3) current use of prescription drugs such as antidepressants or other medications with known sexual side effects (e.g., glucocorticoids, aromatase inhibitors), or known effects on cortisol metabolism, or use of illicit drugs
- (4) use of hormone replacement therapy or hormonal contraceptives;
- (5) a body mass index (BMI) <18.5 or >29.9
- (6) cigarette smoking
- (7) chronic medical or psychiatric disease with potential to interfere with sexual function (e.g., chronic neurological disease, cardiac and liver disease, eating disorders, anxiety disorders)
- (8) chronic pain with intercourse not relieved by a vaginal lubricant
- (9) loss of genital responsiveness
- (10) significant relationship discord
- (11) not having a family physician who we could contact if depression is diagnosed during the assessment
- (12) difficulty in complying with questionnaires or in completing interview.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
HSDD group
Women with a diagnosis of Hypoactive Sexual Desire Disorder (HSDD).
|
Control Group
Women without a diagnosis of Hypoactive Sexual Desire Disorder (HSDD).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
DHEA levels
Time Frame: Data is collected at 4 time points on 3 separate days
|
DHEA levels derived from saliva samples.
|
Data is collected at 4 time points on 3 separate days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cortisol levels
Time Frame: Data is collected at 4 time points on 3 separate days
|
Cortisol levels derived from saliva samples.
|
Data is collected at 4 time points on 3 separate days
|
Depression
Time Frame: data is collected at single time point
|
Depression will be measured by the Beck Depression Inventory (Beck & Beamesderfer, 1974)
|
data is collected at single time point
|
Perceived stress
Time Frame: data is collected at a single time point
|
Perceived stress will be measured with the 10-item Perceived Stress Scale (Roberti, Harrington & Storch 2006)
|
data is collected at a single time point
|
Sexual function
Time Frame: data is collected at a single time point
|
Self-report sexual function will be measured with the Sexual Interest and Desire Inventory (Clayton et al. 2006))
|
data is collected at a single time point
|
Relationship satisfaction
Time Frame: data is collected at a single time point
|
Relationship satisfaction will be measured with the Relationship Assessment Scale (Hendrick, 1988) and the Dyadic Adjustment Scale (Spanier, 1976)
|
data is collected at a single time point
|
History of childhood trauma
Time Frame: dat is collected at a single timepoint
|
History of childhood trauma will be determined with the Childhood Trauma Questionnaire (Bernstein & Fink, 1995)
|
dat is collected at a single timepoint
|
History of childhood sexual abuse
Time Frame: data is collected at a single time point
|
History of Childhood Sexual Abuse will be determined with the Childhood Sexual Abuse Measure (Finkelhor, 1979)
|
data is collected at a single time point
|
PTSD symptoms
Time Frame: data is collected at a single time point
|
Presence and severity of post traumatic stress disorder symptoms will be determined through the Clinician-Administered PTSD Scale (Blake et al. 1998)
|
data is collected at a single time point
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Rosemary Basson, MD, University of British Columbia
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2012
Primary Completion (ACTUAL)
November 1, 2016
Study Completion (ACTUAL)
November 1, 2016
Study Registration Dates
First Submitted
August 27, 2012
First Submitted That Met QC Criteria
October 5, 2012
First Posted (ESTIMATE)
October 8, 2012
Study Record Updates
Last Update Posted (ACTUAL)
October 17, 2018
Last Update Submitted That Met QC Criteria
October 15, 2018
Last Verified
May 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H10-02067
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypoactive Sexual Desire Disorder (HSDD)
-
Ivix LLXCompletedHypoactive Sexual Desire Disorder (HSDD)Russian Federation
-
Ivix LLXCompletedHypoactive Sexual Desire Disorder(HSDD)Russian Federation
-
Warner ChilcottCompletedHypoactive Sexual Desire Disorder (HSDD)United States, Australia, Canada
-
EndoCeutics Inc.AMAG Pharmaceuticals, Inc.WithdrawnHypoactive Sexual Desire Disorder (HSDD)United States
-
TriHealth Inc.TriHealth Medical Education Research FundCompletedHypoactive Sexual Desire Disorder (HSDD) | Low Libido | Female Sexual Dysfunction (FSD)United States
-
Federal University of Minas GeraisCompletedHypoactive Sexual Desire DisfunctionBrazil
-
S1 Biopharma, Inc.CompletedHypoactive Sexual Desire Disorder (DSM-IV-TR Defined) | Sexual Interest/Arousal Disorder (DSM-5 Defined)United States
-
Bezmialem Vakif UniversityUnknownMenopause | Hypoactive Sexual Desire Disorder | Sexual Desire DisorderTurkey
-
Ivix LLXCompletedFemale Sexual Dysfunction | Hypoactive Sexual Desire Disorder | Sexual Desire DisorderRussian Federation
-
Kwang Dong Pharmaceutical co., ltd.RecruitingHypoactive Sexual Desire DisorderKorea, Republic of